Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints were ...
Pelican-2 joins Pelican-1 (a smallsat platform tech demonstration launched last year) as part of Planet’s next-generation, high-resolution fleet, to support and expand its existing SkySat capabilities ...